These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9526675)

  • 1. Differential ability of cells to promote oxidation of low density lipoproteins in vitro.
    Fernando RL; Varghese Z; Moorhead JF
    Clin Chim Acta; 1998 Jan; 269(2):159-73. PubMed ID: 9526675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro.
    Fernando RL; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1993; 8(6):512-8. PubMed ID: 8394531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation.
    Kamanna VS; Pai R; Roh DD; Kirschenbaum MA
    Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion.
    Müller K; Carpenter KL; Mitchinson MJ
    Free Radic Res; 1998 Sep; 29(3):207-20. PubMed ID: 9802552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury.
    Wheeler DC; Chana RS; Topley N; Petersen MM; Davies M; Williams JD
    Kidney Int; 1994 Jun; 45(6):1628-36. PubMed ID: 7933810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative modification of low-density lipoproteins by mesangial cells.
    Keane WF; O'Donnell MP; Kasiske BL; Kim Y
    J Am Soc Nephrol; 1993 Aug; 4(2):187-94. PubMed ID: 8400082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Campione AL; Moore MK
    Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein oxidation is increased in kidney transplant recipients.
    van den Dorpel MA; Ghanem H; Rischen-Vos J; Man in 't Veld AJ; Jansen H; Weimar W
    Transpl Int; 1996; 9 Suppl 1():S54-7. PubMed ID: 8959791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein.
    Neugarten J; Ghossein C; Silbiger S
    J Lab Clin Med; 1995 Oct; 126(4):385-91. PubMed ID: 7561448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.
    Dittrich R; Dragonas C; Mueller A; Maltaris T; Rupp J; Beckmann MW; Maass M
    Biochem Biophys Res Commun; 2004 Jun; 319(2):501-5. PubMed ID: 15178434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native and oxidized low density lipoproteins modulate mesangial cell apoptosis.
    Sharma P; Reddy K; Franki N; Sanwal V; Sankaran R; Ahuja TS; Gibbons N; Mattana J; Singhal PC
    Kidney Int; 1996 Nov; 50(5):1604-11. PubMed ID: 8914027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells.
    Allen S; Khan S; Al-Mohanna F; Batten P; Yacoub M
    J Clin Invest; 1998 Mar; 101(5):1064-75. PubMed ID: 9486977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
    Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
    Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
    Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent data about the LDL-atherogenesis relationship].
    Păduraru I; Hurjui J; Filimon O; Filimon M; Saramet A; Petriş O; Lionte C
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):31-6. PubMed ID: 12092155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.
    Hamilton CA
    Pharmacol Ther; 1997; 74(1):55-72. PubMed ID: 9336016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.